8-K
filed May 21, 2026, 4:30 PM ET
ticker CLPT
CIK 0001285550
other material
confidence high
sentiment neutral
materiality 0.55
ClearPoint Neuro shareholders approve 1M share increase in 2013 incentive plan; board committees reappointed
ClearPoint Neuro, Inc.
- Shareholders approved 7th Amended 2013 Incentive Compensation Plan, increasing share pool by 1,000,000 shares to 7,806,250 total.
- All seven director nominees elected with >96% votes for each: Burnett, Fallon, Fletcher, Johnson, Klein, Liau, Richards.
- Ratification of Cherry Bekaert LLP as auditor: 19.3M for, 20K against; advisory executive compensation approved 8.8M for, 442K against.
- Board committees reappointed: Audit (Fallon chair), Compensation (Johnson chair), Governance (Fletcher chair); Fletcher confirmed as Chairman.
- Non-employee director annual award cap set at 60,000 shares per year under the amended plan.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ClearPoint Neuro, Inc. shareholders approved Approval of the Seventh Amended and Restated 2013 Incentive Compensation Plan.
- Proposal
- equity plan
- Outcome
- passed
Exact text from the filing
The stockholders approved the Company's Seventh Amended and Restated 2013 Incentive Compensation Plan. The votes were cast as follows: For Against Abstentions Broker Non-Votes 7,517,634 1,793,261 495,788 9,991,790
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ClearPoint Neuro, Inc. shareholders approved Election of seven directors to serve until the 2027 annual meeting.
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
The following named persons were elected as directors of the Company to serve until the 2027 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal. The votes were cast as follows: Name For Withheld Broker Non-Votes Joseph M. Burnett 9,686,224 120,459 9,991,790 Lynnette C. Fallon 9,625,049 181,634 9,991,790 R. John Fletcher 9,676,332 130,351 9,991,790 B. Kristine Johnson 9,628,069 178,614 9,991,790 Matthew B. Klein 9,639,952 166,731 9,991,790 Linda M. Liau 9,601,872 204,811 9,991,790 Timothy T. Richards 9,639,577 167,106 9,991,790
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ClearPoint Neuro, Inc. shareholders approved Advisory approval of executive compensation.
- Proposal
- say on pay
- Outcome
- passed
Exact text from the filing
The stockholders, on an advisory basis, approved the compensation of the Company's executives. The votes were cast as follows: For Against Abstentions Broker Non-Votes 8,825,126 442,728 538,829 9,991,790
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ClearPoint Neuro, Inc. shareholders approved Ratification of the appointment of Cherry Bekaert LLP as the Company's independent registered public accounting firm at the 2026-12-31 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-12-31
Exact text from the filing
The stockholders ratified the selection of Cherry Bekaert LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes were cast as follows: For Against Abstentions Broker Non-Votes 19,296,330 20,086 482,057 0
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.